Bayer presents adenosine A2B receptor antagonists and IL-6 release inhibitors April 16, 2018 No Comments
FDA removes clinical hold and allows initiation of phase I/II study of MRT-5005 April 16, 2018 No Comments
CNTO-3157 fails to attenuate rhinovirus-induced experimental asthma exacerbations April 12, 2018 No Comments
RP-5063 granted FDA orphan drug designation for the treatment of idiopathic pulmonary fibrosis April 10, 2018 No Comments
Triple combination program for the treatment of cystic fibrosis receives FDA fast track designation April 5, 2018 No Comments
RSS